Rainbow Children's Medicare IPO
Rainbow Children's Medicare Ltd.
₹13,932 /27 sharesMinimum Investment
Rainbow Children's Medicare IPO Details
| Bidding Dates | Min. Investment | Lot Size | Price Range |
|---|---|---|---|
| 27 Apr ‘22 - 29 Apr ‘22 | ₹13,932 | 27 | ₹516 - ₹542 |
| Issue Size | IPO Doc |
|---|---|
| 1581.00Cr | RHP PDF |
Subscription Status As on 29 Apr '22, 5:00 PM
- Retail Individual Investor1.38x
- Non-Institutional Investor3.73x
- Qualified Institutional Buyers38.90x
- Employees0.31x
- Total12.43x
About Rainbow Children's Medicare
Rainbow Children's Medicare is a multi-specialty pediatric and obstetrics and gynecology hospital chain in India. It operates 14 hospitals and three clinics in six cities, with a total bed capacity of 1,500 beds, as per the latest information available. The IPO includes a fresh issue portion and an offer for sale. The net proceeds of the fresh issue portion may be used for early redemption of Non-Convertible Debentures (NCDs) issued by the company, in full, and capital expenditure towards setting up of new hospitals and purchase of medical equipment for such new hospitals. ;
Parent Organisation
Rainbow Children's Medicare Ltd.
Founded
1998
Managing Director
Ramesh Kancharla
Detailed IPO Analysis: Rainbow Children's Medicare | Should you apply for Rainbow Children's IPO?
Strengths & Risks
- Specialization in pediatric care.
- Presence across various specialties such as neurology, nephrology, gastroenterology, oncology, and cardiology.
- Extensive transportation network in and around Hyderabad - in the financial year 2021, the company transported 796 long-distance patients to its hospitals in Hyderabad.
- As per CRISIL Research, among the key players in the maternity and pediatric healthcare delivery sector, Rainbow Children’s Medicare had the highest number of hospital beds, as of March 31, 2021.*
- Comprehensive perinatal care provider, with synergies between pediatric and obstetrics and gynecology services.
- Doctor engagement model whereby most of the core specialists work exclusively at its hospitals on a full-time retainer basis.
- Over the last six years, the company has added 985 beds across 10 hospitals and expanded its presence from two cities to six cities.
- Nine of the company’s hospitals are recognized by the National Board of Examination (“DNB”), the Indian Association of Pediatrics (“IAP”), and the National Neonatology Forum (“NNF”) for training doctors in pediatric, neonatology, pediatric subspecialties, obstetrics, and gynecology.
- High dependence on the skills, efforts, and experience of medical professionals - inability in attracting and retaining such medical professionals can affect the business.
- Engagement of doctors primarily on a consultancy service contract basis - no assurance that the doctors will not prematurely terminate their agreements.
- Non-compliance with applicable safety, health, environmental, labour, and other regulations, or failure to obtain or renew approvals, licenses, registrations, and permits, may adversely affect the business,
- Intense competition from other healthcare service providers.
- Revenues are highly dependent on hospitals in Hyderabad and Bengaluru - of the total 14 hospitals, six are situated in Hyderabad and three are situated in Bengaluru.
- The company has made applications for the registration of the word mark “Birth Right” in Tamil, Kannada, and English. However, a third party, Nextline Diagnostics LLP has opposed the registration of these trademarks in India.
- As of September 30, 2021, the company’s borrowings (current and non-current) amounted to Rs 42.73 crore on a consolidated basis.
- The company outsources some of its service functions to third-party contractors - any lapse by such third-party service contractors may have adverse consequences on the business and reputation.
- Outstanding legal proceedings involving the company, its promoters, subsidiaries, directors, and its group companies.
- The company has in the past entered into related party transactions and will continue to do so in the future - there is no assurance that the company could not have achieved more favourable terms if such transactions had not been entered into with related parties.
- The business is affected by seasonality and the company typically has fewer patient visits during the months of March to May.
- *the CRISIL report was commissioned and paid for by the company in relation to the Offer.
Financials
*All values are in Rs. Cr
No Graph Data To Display
Application details
| Apply as | Price band | Apply upto |
|---|---|---|
| Regular | ₹516 - 542 | ₹2 Lakh |
For Rainbow Children's Medicare IPO, eligible investors can apply as Regular.
MOST POPULAR ON GROWWVERSION - 4.5.1
STOCK MARKET INDICES: S&P BSE SENSEX | S&P BSE 100 | NIFTY 100 | NIFTY 50 | NIFTY MIDCAP 100 | NIFTY BANK | NIFTY NEXT 50
POPULAR MUTUAL FUNDS: QUANT SMALL CAP FUND | ICICI PRUDENTIAL COMMODITIES FUND | NIPPON INDIA SMALL CAP FUND | PARAG PARIKH FLEXI CAP FUND | QUANT TAX PLAN | SBI SMALL MIDCAP FUND | TATA DIGITAL INDIA FUND | AXIS SMALL CAP FUND | ICICI PRUDENTIAL TECHNOLOGY FUND | HDFC INDEX FUND SENSEX PLAN | HDFC SMALL CAP FUND | AXIS EQUITY FUND | CANARA ROBECO SMALL CAP FUND | TATA SMALL CAP FUND | UTI NIFTY FUND
MUTUAL FUNDS COMPANIES: GROWWMF | SBI | AXIS | HDFC | UTI | NIPPON INDIA | ICICI PRUDENTIAL | TATA | KOTAK MAHINDRA | DSP | CANARA ROBECO | SUNDARAM | MIRAE ASSET | BANDHAN | FRANKLIN TEMPLETON | PPFAS | MOTILAL OSWAL | INVESCO | EDELWEISS | ADITYA BIRLA SUN LIFE | LIC | HSBC | NAVI | QUANTUM | UNION | IDBI | ITI | MAHINDRA MANULIFE | 360 ONE | BOI | TAURUS | JM FINANCIAL | PGIM | SHRIRAM | BARODA BNP PARIBAS | QUANT | WHITEOAK CAPITAL | TRUST | SAMCO | NJ | BAJAJ